Outcome | Tertile 1 | Tertile 2 | Tertile 3 | p-trend |
---|---|---|---|---|
Apo A1/(VLDL 3 -C+IDL-C) | Â | Â | Â | Â |
1 year Death/MI | 9.7% (23) | 7.6% (18) | 6.3% (15) | 0.17 |
3 year Death/MI | 17.3% (41) | 15.6% (37) | 9.3% (22) | 0.01 |
Apo A1 | Â | Â | Â | Â |
1 year Death/MI | 11.4% (27) | 5.5% (13) | 6.8% (16) | 0.06 |
3 year Death/MI | 21.1% (50) | 9.3% (22) | 11.8% (28) | 0.004 |
Apo B | Â | Â | Â | Â |
1 year Death/MI | 6.3% (15) | 10.1% (24) | 7.2% (17) | 0.27 |
3 year Death/MI | 13.9% (33) | 16.0% (38) | 12.2% (29) | 0.49 |
Apo B/A1 | Â | Â | Â | Â |
1 year Death/MI | 7.2% (17) | 5.1% (12) | 11.4% (27) | 0.03 |
3 year Death/MI | 12.2% (29) | 11.4% (27) | 18.6% (44) | 0.05 |
HDL-C | Â | Â | Â | Â |
1 year Death/MI | 8.4% (20) | 6.6% (15) | 8.5% (21) | 0.98 |
3 year Death/MI | 18.6% (44) | 10.2% (23) | 13.3% (33) | 0.10 |
Triglycerides | Â | Â | Â | Â |
1 year Death/MI | 7.7% (18) | 9.2% (22) | 6.8% (16) | 0.72 |
3 year Death/MI | 12.3% (29) | 15.4% (37) | 14.4% (34) | 0.52 |
LDL-C | Â | Â | Â | Â |
1 year Death/MI | 8.3% (20) | 8.2% (19) | 7.1% (17) | 0.63 |
3 year Death/MI | 16.3% (39) | 12.9% (30) | 13.0% (31) | 0.31 |
non-HDL-C | Â | Â | Â | Â |
1 year Death/MI | 6.8% (16) | 10.2% (24) | 6.7% (16) | 0.96 |
3 year Death/MI | 14.0% (33) | 16.6% (39) | 11.7% (28) | 0.46 |
Triglycerides/HDL-C Ratio | Â | Â | Â | Â |
1 year Death/MI | 7.9% (23) | 9.1% (21) | 6.4% (12) | 0.64 |
3 year Death/MI | 11.6% (34) | 17.2% (40) | 13.9% (26) | 0.37 |
VLDL 3 -C+IDL-C | Â | Â | Â | Â |
1 year Death/MI | 6.8% (17) | 7.4% (16) | 9.3% (23) | 0.29 |
3 year Death/MI | 11.6% (29) | 15.8% (34) | 15.0% (37) | 0.27 |
Total Cholesterol/HDL-C Ratio | Â | Â | Â | Â |
1 year Death/MI | 8.9% (21) | 7.6% (18) | 7.2% (17) | 0.78 |
3 year Death/MI | 13.5% (32) | 12.6% (30) | 16.1% (38) | 0.52 |
HDL-C/(VLDL 3 -C+IDL-C) | Â | Â | Â | Â |
1 year Death/MI | 10.6% (25) | 6.3% (15) | 6.7% (16) | 0.12 |
3 year Death/MI | 19.1% (45) | 13.0% (31) | 10.1% (24) | 0.005 |
LDL-C/HDL-C | Â | Â | Â | Â |
1 year Death/MI | 9.7% (23) | 5.5% (13) | 8.4% (20) | 0.61 |
3 year Death/MI | 14.3% (34) | 11.4% (27) | 16.5% (39) | 0.51 |